BCG With or Without Gefitinib in Treating Patients With High-Risk Bladder Cancer
- Status
- TERMINATED
- Phase
- PHASE3
Clinical Trials Related to Bladder Cancer
Related studies linked through entity extraction aliases.
Bladder Cancer Chemoradiation Using Intensity Modulated Radiation Therapy
- Status
- TERMINATED
- Phase
- NA
The New England Bladder Cancer Study
- Status
- COMPLETED
- Phase
- N/A
Interdisciplinary Case-Control Study of Bladder Cancer in Spain
- Status
- COMPLETED
- Phase
- N/A
Exercise in Improving Mobility and Reducing Fatigue and/or Weakness in Older Cancer Survivors
- Status
- COMPLETED
- Phase
- NA
Safety Study of Recombinant Human Hyaluronidase (Chemophase) in Combination With Mitomycin in Participants With Superficial Bladder Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
NMP22 Provides Improved Sensitivity in Detecting Bladder Cancers.
- Status
- COMPLETED
- Phase
- N/A
Survivin Urine mRNA Assay Risk of Bladder Cancer Study
- Status
- COMPLETED
- Phase
- N/A
Phase III Trial of Vinflunine Plus Best Supportive Care vs. Best Supportive Care in Patients With Transitional Cell Carcinoma (TCC) of the Urothelial Tract
- Status
- COMPLETED
- Phase
- PHASE3
Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Motivational Counseling in Preventing Smoking Relapse After Pregnancy in Pregnant Women Who Quit Smoking During Pregnancy
- Status
- COMPLETED
- Phase
- N/A
Gemcitabine, Paclitaxel, and Cisplatin in Treating Patients With Advanced Cancer of the Urothelium
- Status
- COMPLETED
- Phase
- PHASE2
Loop Resectoscope in Treating Patients With Bladder Cancer or Benign Prostatic Hyperplasia Who Are Undergoing Transurethral Resection
- Status
- COMPLETED
- Phase
- NA
Cisplatin, Bevacizumab, and Gemcitabine Followed by Surgery, Bevacizumab, and Paclitaxel in Treating Patients With Locally Advanced Nonmetastatic Bladder Cancer That Can Be Removed By Surgery
- Status
- TERMINATED
- Phase
- PHASE2
Phase II Gemcitabine + Cisplatin +/- Iressa Bladder CCT
- Status
- COMPLETED
- Phase
- PHASE2
Identifying Methylation Biomarkers for Monitoring Bladder Tumors
- Status
- UNKNOWN
- Phase
- N/A
Randomized Phase III Trial of Leukine® vs Neupogen® in Patients Receiving Cisplatin & Gemcitabine for Urothelial Cancer
- Status
- TERMINATED
- Phase
- PHASE3
Cisplatin, Gemcitabine and Bevacizumab in Combination for Metastatic Transitional Cell Cancer
- Status
- COMPLETED
- Phase
- PHASE2
S0353, Gemcitabine in Treating Patients With Recurrent Bladder Cancer That Has Not Responded to Previous Bacillus Calmette-Guerin
- Status
- COMPLETED
- Phase
- PHASE2
Study to Improve Detection and Early Recurrence Rate in Bladder Cancer Patients Using Hexvix Fluorescence Cystoscopy
- Status
- COMPLETED
- Phase
- PHASE3